Abstract A recent development in biomedical imaging is the non-invasive mapping of molecular events in intact tissues using fluorescence. Underpinning to this development is the discovery of bio-compatible, specific fluorescent probes and proteins and the development of highly sensitive imaging technologies for in vivo fluorescent detection. Of particular interest are fluorochromes that emit in the near infrared (NIR), a spectral window, whereas hemoglobin and water absorb minimally so as to allow photons to penetrate for several centimetres in tissue. In this review article we concentrate on optical imaging technologies used for noninvasive imaging of the distribution of such probes. We illuminate the advantages and limitations of simple photographic methods and turn our attention to fluorescence-mediated molecular tomography (FMT), a technique that can three-dimensionally image gene expression by resolving fluorescence activation in deep tissues. We describe theoretical specifics, and we provide insight into its in vivo capacity and the sensitivity achieved. Finally, we discuss its clinical feasibility.
Introduction
Tissue observation with light is probably the most common imaging practice in medicine and biomedical research ranging from the simple visual inspection of a patient to advanced in vivo and in vitro spectroscopic and microscopy techniques [1] . While intrinsic tissue absorption and scattering yields significant information on functional and anatomical tissue characteristics, significant attention has also been given to fluorescence investigations of tissue since many biochemical markers can be retrieved due to fluorescence contrast, and many more can be targeted using appropriate fluorescent markers [2, 3] .
Numerous different optical imaging approaches can be used for imaging fluorescence in vivo. Traditionally, optical methods have been used to look at surface and subsurface fluorescent events using confocal imaging [4, 5, 6] , multiphoton imaging [7, 8, 9 , 10] microscopic imaging by intravital microscopy [11, 12] or total internal reflection fluorescence microscopy [13] . Recently however, light has been used for in vivo interrogations deeper into tissue using photographic systems with continuous light [14, 15, 16, 17] or with intensity-modulated light [18] and tomographic systems [19, 20] . Potentially, phased-array detection [21] can also be applied. This recent focus in macroscopic observations of fluorescence in tissues has evolved due to the potential of transferring this technology to imaging through animals and humans [2] . This technology has become feasible mainly due to the development of fluorescence probes emitting in the near-infrared spectrum where tissue offers low absorption, highly sensitive detectors and monochomatic light sources (lasers) with higher but nevertheless safely delivered power per wavelength compared with white-light illuminators. While macroscopic fluorescence imaging in the visible has also been attempted using fluorescent proteins, the penetration depth is limited to only 1-2 mm [16] , whereas it has been predicted that NIR fluorescent light can penetrate for several centimeters [22] . Such an approach could enable investigations available currently only for in vitro studies to propagate in in vivo human disease diagnosis and imaging of treatment response and significantly enhance the field of molecular imaging [2] .
In this article we discuss imaging techniques that use the diffuse component of light for probing molecular events deep in tissue. Specifically, we focus on reflectance fluorescence imaging and fluorescence-mediated molecular tomography (FMT), which are the two most common approaches currently used for imaging fluorescent probes in deep tissues. We further discuss recent findings that predict the capacity of near-infrared fluorescent signals to propagate through human tissue for non-invasive medical imaging and address feasibility issues for clinical studies.
Reflectance imaging
Technology Simple "photographic methods", in which the light source and the detector reside on the same side of the animal imaged, are generally referred to as "reflectance imaging". Reflectance imaging is currently the typical method of choice for accessing the distribution of fluorescent probes in vivo, but the method can be applied more generally to imaging fluorescent proteins or even bioluminescence even if in the latter case no excitation light is used [23] .
Near-infrared fluorescence reflectance imaging in particular operates on light with a defined bandwidth as a source of photons that encounters a fluorescent molecule ("optical contrast agent or molecular probe"), which emits a signal with different spectral characteristics, that can be resolved with an emission filter and captured by a high-sensitivity CCD camera.
A typical reflectance imaging system is shown in Fig. 1 . The light source can be either a laser at an appropriate wavelength for the fluorochrome targeted or white light sources using appropriate low-pass filters. Generally, laser sources are preferable because they offer higher power delivery at narrower and better-defined spectral windows (typically ±3 nm for laser diodes vs ±10 nm or more for filtered white-light sources). The laser beam is expanded on the animal surface with an optical system of lenses (not shown). Narrow wavelength selection is important, especially in the NIR, whereas the excitation and emission spectra overlap and it is likely that excitation photons can propagate into the fluorescent images. The CCD camera is usually a high-sensitivity camera since fluorescent signals are of low strength. On the other hand, since the targeted measurement is a diffuse-light measurement, emanating from a virtually flat surface, CCD chip resolution and dynamic range are not crucial factors in these types of systems. Also the noise requirements of a CCD camera for fluorescence imaging are not as stringent since in the general case the detection sensitivity limit is set by the background tissue fluorescence (background probe distribution and auto-fluorescence), and fluorescence strength can be adjusted above the camera noise floor by optimizing illumination strength and acquisition times. These features are in contrast to bioluminescence measurements, where the detection sensitivity is usually set by the CCD camera noise floor. Detection systems that scan a single spot over a field of view and detect light using photo-multiplier tube detectors have also been reported [24] . Such systems may offer greater dynamic range than CCD-based systems but compromise resolution, acquisition frame rate, and overall noise characteristics, and are not widely used in in vivo fluorescence reflectance measurements.
Typically, the fluorescence image acquired (see example in Fig. 2a ) is accompanied by a second image, shown in Fig. 2b , which is measured without the fluorescence filter to obtain a "photograph" of the animal for registration purposes at the excitation wavelength. This intrinsic light image also serves as a calibration measurement since it records the exact spatial distribution of the excitation light strength for later correction of excitation field inhomogeneities. Figure 2 depicts a measurement from a nude mouse with a cathepsin B rich HT1080 fibrosarcoma, which had been implanted (10 5 cells) into [27] using activatable probes, i.e., appropriately engineered fluorochromes that are dark in their native (quenched) state and fluoresce only upon interaction with specific proteases. A representative mechanism of activation is shown in Fig. 3 . In the non-activated state fluorochromes are loaded in closed proximity onto a graft copolymer consisting of a poly-lysine (PL) backbone through appropriate peptides and undergo mutual energy transfer; thus, they exist in a quenched state. At the presence of the targeted enzyme, cleavage of the peptide link releases the fluorochromes which results in a bright fluorescence signal, which can be detected in vivo.
A characteristic example of this technology applied to elucidate different expression levels of tumor MMP-2 activity is shown in Fig. 4 using an MMP-2-positive human HT1080 fibrosarcoma and an MMP-2-negative BT20 mammary adenocarcinoma [28] . Both types of 3 An example of an activatable probe. These probes are dark in their native state, but after enzymatic cleavage of the backbone carrier they fluoresce when appropriately excited breast cancers activated the near-infrared probe, but the activation at the HT1080 tumor was markedly higher than the BT-20 tumor which was barely differentiable from the background activation. The different levels of enzyme secretion in the two tumor cell lines used were further verified by zymographic studies [28] as shown in Fig. 4c .
Reflectance imaging has also been used for targeting cell-surface receptors in vivo using peptide near-infrared dye conjugates [15, 29] . Figure 5 depicts fluorescence reflectance images using a conjugate of tricarbocyanine dye and an octapeptide (c.f. Fig. 5a ) for targeting the somatostatin receptor in CA20948 tumor-bearing rats [29, 30] . The tumor cells were implanted subcutaneously in the left flank of the rat demonstrating a marked fluorescence increase compared with surrounding tissues (Fig. 5b, c) . Similar observations were performed in a separate study [15] that showed significant fluorescence increase from tumor sites compared with normal tissues using the somatostatin analog octreotate coupled to indocarbocyanine dyes. Specifically, the fluorescence detected before the injection of the dye-peptide conjugate administered in a tumor-bearing mouse (RIN38 pancreatic tumor expressing the somatostatin receptor subtype 2) and a control mouse are shown in Fig. 6a and b, respectively. Figure 6c and d show the fluorescence images obtained from the same animals 6 h after probe injection. The administered probe dose was 0.02 µmol/kg body weight. The receptor-binding indotricarbocyanineoctreotate conjugate leads to a significantly elevated tumor signal (Fig. 6c) , whereas a control conjugate with no receptor affinity does not generate contrast (Fig. 6d) . The relative fluorescence intensities of tumor tissue and normal tissue in the tumors studied with two different dye conjugates are shown in Fig. 6e and f (indodicarbocyanine-octreotate, Fig. 6e ; and indotricarbocyanine-octreotate, Fig. 6f ) at different times after application. The time course of tumor-to-normal contrast is depicted for both compounds in Fig. 6g . Figure 6h shows the results of a biodistribution analysis of 125I-ITCC-octreotate in RIN38 tumor-bearing nude mice 24 h post injection. Tissue distribution of this double-labeled peptide derivative is given as percentage injected dose per gram.
More generally, reflectance imaging can be used to macroscopically assess endogenous gene products by using fluorescent proteins [16, 31] . Imaging of florescent proteins (FP) can be done in analogy to near-infrared imaging with the following exceptions: In a similar paradigm, bioluminescence imaging [32] is based on emission of visible photons at specific wavelengths based on energy-dependent reactions catalyzed by luciferases. Luciferase genes have been cloned from a large number of organisms, including bacteria, firefly (Photinus pyralis), coral (Renilla), jellyfish (Aequorea), and dinoflagellates (Gonyaulax). In the firefly, luciferase utilizes energy from ATP to convert its substrate luciferin to oxyluciferin, with the emission of a detectable photon. Sensitive imaging systems have been built to detect quantitatively a small number of cells or organisms expressing luciferase as a transgene [33] .
Multi-spectral imaging
An exciting approach in optical imaging is capitalizing on the spectral differentiation of different fluorochromes in order to perform concurrent imaging of multiple targets [34] . This can be achieved by using appropriate filters in front of the CCD detector that can selectively acquire images at different wavelengths. Figure 7 exemplifies this approach by showing images of GFP and cathepsin B expression obtained from a nude mouse implanted subcutaneously with GFP positive 9L glioma tumors on the right side and GFP negative 9L glioma tumors on the left side [34] . Both tumors were expressing cathepsin B, which was imaged with a cathepsin-B sensitive probe [25] loaded with the Cy5.5 fluorochrome (Amersham Pharmacia Biotech, Piscataway, N.J.). The images were acquired consecutively using appropriate filters in front of the detector for imaging at the GFP spectral window (500-550 nm) and at the Cy5.5 dye channel (690-740 nm) and demonstrate the ability to image separate gene expressions in vivo
Advantages and limitations
Reflectance imaging is an ideal tool for high-throughput imaging and screening of surface fluorescent events in vivo or in excised tissues. It offers simplicity of operation and high sensitivity for molecular events that are close to the surface. Typical acquisition times range from a few seconds to a few minutes. For laboratory settings, multiple animals can be simultaneously imaged. Hardware development and implementation is also straightforward and relatively inexpensive. Reflectance systems do not use ionizing radiation, employ safe laser powers, can be made portable and attain small space requirements to be ideal for the laboratory bench.
On the other hand, reflectance imaging has fundamental limitations both as a research or clinical tool. Firstly, the technique attains only small penetration depths (a few millimeters). This is because the appearance of deeper lesions is significantly blurred and the signal detected from them is significantly attenuated as a function of lesion depth while the background noise remains constant in reflectance mode since it consists of fluorescence signals from superficial layers and intrinsic light contaminating the fluorescence measurement due to imperfect filtering. This is in contrast to tomographic methods (discussed in the next section) where both signal and noise reduces so that signal to noise remains significant for lesions that are much deeper than a few millimeters. Secondly, reflectance imaging is not capable of quantification as illustrated in Fig. 8 . A small structure of high fluorochrome concentration that is deeper into tissue could yield the same appearance on the surface as a larger structure of low fluorochrome concentration that is closer to the surface. This is due to the nature of propagation of diffuse photon density waves into tissue. The photon count reading at a surface of an animal due to a lesion on or under the surface depends on the lesion depth, the lesion volume and the optical properties of both the lesion and the surrounding tissue; therefore, images from different animals, or from the same animal at different time points, are generally insufficient for yielding quantitative insights. 
Fluorescence-mediated molecular tomography
In order to resolve and quantify fluorochromes deep in tissue tomographic approaches are necessary. The general framework of reconstruction techniques using diffuse light has been developed during the last decade where rigorous mathematical modeling of light propagation in tissue, combined with technological advancements in photon sources and detection techniques has made possible the application of tomographic principles [35, 36, 37, 38, 39, 40] for optical imaging. The technique, generally termed diffuse optical tomography (DOT), uses multiple projections and measures light around the boundary of the illuminated body. It then effectively combines all measurements into an inversion scheme that takes into account the highly scattered photon propagation to deconvolve the effect of tissue on the propagating wave, even though high frequency components are generally significantly attenuated and the resolution impaired. Diffuse optical tomography has been used for quantitative imaging of absorption and scattering [41, 42, 43, 44, 45, 46] as well as concentration and fluorochrome lifetime measurements with simulated or phantom measurements [47, 48, 49, 50, 51, 52] . Recently, DOT has been applied clinically for imaging tissue oxy-and deoxy-hemoglobin concentration and blood saturation [53, 54, 55] and contrast agent uptake in absorption mode [56] .
A particular development that facilitates in vivo molecular interrogations of tissue is the use of fluorescence molecular tomography (FMT) [20] . The method produces quantified three-dimensional reconstructions of fluorescence activation or concentration using measurements of fluorescent molecular probes at both the emission and excitation wavelengths. The theoretical mainframe has been described elsewhere [52] . The main advantage of using both intrinsic and fluorescence contrast is that no absolute photon-field measurements are required, yet absolute fluorochrome concentrations can be reconstructed. Furthermore, the method does not require any measurements obtained before contrast agent administration, which is a crucial parameter for in vivo imaging of probes that require long circulation times to achieve sufficient accumulation in their intended targets.
FMT imaging systems
In order to perform fluorescence tomography, tissue has to be illuminated at different projections and multiple measurements should be collected from the boundary of the tissue of investigation. FMT, in its simplest imple- mentation, needs only measurements of fluorescence and intrinsic light using constant-wave sources in order to resolve the single quantity targeted, namely fluorochrome concentration. This is in contrast to DOT which, in its general form, requires decomposition of absorption from scattering and therefore requires more elaborate photon technologies such as intensity-modulated sources or short photon pulses and appropriate detection systems. The ability of FMT to operate with constant wave systems allows for a practical and relatively inexpensive implementation of multiple detection channels using CCD cameras. In CW mode, CCD cameras offer very high sensitivity and low noise levels. Nevertheless, the use of advanced photon sources and detection systems can enhance tomographic performance by potentially improving resolution and resolving lifetime as well [48, 49] .
A CCD-based FMT system example is shown in Fig. 9a . The light source (i) is generally a laser diode at the appropriate wavelength to excite the targeted fluorochrome. Multiple laser diodes at different wavelengths could be combined in the same system (either by time sharing or spectral separation) to excite multiple fluorochromes simultaneously. The light from the laser diode can be directed to an optical switch (ii) for time sharing one input to many outputs and directed with optical fibers (iii) at different points around the body of investigation or a specially designed "optical bore" (iv). Our implementation of an optical bore [57] is shown in Fig. 9b . The optical bore contains the body of examination similar to a CT or MR scanner. Typically, such an implementation would require the animal immersed into a "matching fluid" (also shown in Fig. 9b contained in the bore), such as a water solution of a scatterer (e.g., TiO 2 particles) and an absorber (India Ink or similar) that matches the optical properties of the tissue investigated. The matching fluid serves virtually the same function as gel to ultrasound. Fiber bundles (v) can be used to collect photons through the turbid medium and direct them onto the CCD camera (viii) either by direct fiber coupling or by an appropriate positioning arrangement (vi) so that the fiber output can be imaged via a lens system as depicted in Fig. 9c . Appropriate filters (vii) are necessary to reject background ambient light and intrinsic or fluorescence signals according to the measurement performed. A reference measurement could also be introduced to account for temporal variations in laser intensity. The use of an optical bore and matching fluid is a convenient approach for matching photons onto tissue but by no means limiting. Different schemes, including direct fiber positioning on the tissue surface, at arbitrary geometries, including geometries, that could be used by endoscopic probes could be devised.
In vivo imaging
The FMT has been used recently for imaging of cathepsin B activity within deep structures. Figure 10 shows a representative experiment of the results obtained from 9L gliosarcomas stereotactically implanted into unilateral brain hemispheres of nude mice, as cathespin B activity had been implicated in glioma invasion [58, 59, 60] . Correlative MR imaging was performed to determine the 202 Fig. 9a-c Example of an FMT scanner. a The scanner uses multiple sources and detectors to effectively collect light measurement at multiple projections around the animal's body. For details see text. b Photograph of the optical bore used for animal investigations. The source fibers (blue) and detection fiber bundles (black) are shown installed. c Photograph of the fiber bundle array arranged for imaging by the CCD camera presence and location of tumors prior to the FMT imaging studies. Figure 10a and b depicts the gadoliniumenhanced tumor (enhancement is shown in a green color map superimposed onto a T1-weighted image) on axial (Fig. 10a) and sagittal (Fig. 10b) slices. Figure 10c , e, and f depicts the three consecutive FMT slices obtained from top to bottom of the volume of interest. The location and volume covered by the three slices is indicated in Fig. 10b by thin white horizontal lines. Figure 10c shows marked local probe activation relative to adjacent slices, congruent with the location of the tumor identified on the MR images. Figure 10d shows a superposition of the MR axial slice passing through the tumor (Fig. 10a) onto the corresponding FMT slice (Fig. 10c) after appropriately translating the MR image to the actual dimensions of the FMT image. For coregistration purposes we used special water-containing fiducials and body marks that facilitated matching of the MR and FMT orientation and animal positioning. The in vivo imaging data correlated well with surface-weighted reflectance imaging of the excised brain. Figure 10g depicts the axial brain section through the 9L tumor examined with white light using a CCD camera mounted onto a dissecting microscope, Fig. 10h shows the same brain section imaged using a previously developed reflectance imaging system [14] at the excitation wavelength (675 nm), and Fig. 10i is the fluorescence image obtained at the emission light wavelength using appropriate three-cavity cut-off filters that demonstrates a marked fluorescent probe activation, congruent with the tumor position identified by gadolinium-enhanced MRI and FMT. The above results confirm that cathepsin B can be used as an imaging marker [25] since the protease is produced in considerable amounts by tumor cells and by recruited host cells [61] . Cathepsin B expression in the tumors was further confirmed by immunohistochemistry, Western blotting and RT-PCR.
Quantification: resolution and coregistration
The feasibility to three-dimensionally reconstruct and quantify fluorochromes embedded in diffuse media has been demonstrated in the past [47, 48, 49, 52] . It has been further shown that FMT can yield linear responses over a wide area of physiologically relevant fluorochrome concentrations [57] . Figure 11 depicts reconstructions obtained for the range 1-800 nM concentration of the Cy5.5 fluorochrome obtained with a system similar to the one shown in Fig. 9 . The geometry employed is shown in Fig. 11a . A 2-mm radius tube was immersed into the optical bore (shown in Fig. 9 ) and contained various concentrations of fluorochromes. A typical reconstructed image is seen in Fig. 11b. Figure 11c plots the reconstructed fluorochrome concentration as a function of the expected concentration. The reconstructed value demonstrates a remarkably linear response for the whole range of examined concentrations [57] .
The resolution limits of diffuse light imaging techniques have been studied theoretically, but there is limited experimental demonstration, mainly due to the lack of high source-detection efficiency systems. Increasing the number of sources and detectors improves resolution not only due to the higher spatial sampling but also due to the improvements in signal-to-noise ratio achieved in increased data sets [62] . Naturally, improvements of source and detector density do not scale linearly with resolution improvements. It is expected that the resolution for small animal imaging would be of the order of 1-2 mm, whereas for larger tissues it would approach 4-5 mm [62] .
The FMT can be combined with high-resolution "reflectance" imaging in superimposing surface architectural features and markers on the underlying threedimensional reconstruction to correlate the tomographic results with anatomical features, especially in animal imaging. Such an example is shown in Fig. 12 . Figure 12a depicts a merged axial FMT/MRI image obtained from the nude mouse shown in Fig. 2 . Figure 12b depicts the sagittal MRI image of the same animal and the three FMT slices imaged. Figure 12c depicts a three-dimensional rendering of the superposition of the three-dimensional FMT images with the two dimensional intrinsic light image (shown in Fig. 2b ) after application of appropriate thresholds. Furthermore, the combination of FMT with high-resolution imaging methods that primarily target structure, such as X-ray CT or MRI, could yield a superior hybrid imaging modality in which highly sensitive molecular information and high resolution is achieved. Such an approach is feasible due to the optical component compatibility with most other medical imaging modalities and has been recently applied to performing clinical investigations of the breast using a combined MRI and DOT system [19] .
Clinical feasibility of fluorescence imaging
Clinical fluorescent imaging would require detection of fluorescent signals that have propagated for several centimeters into tissue. Figure 13a demonstrates the photon attenuation rate of different human tissues. In particular, it is shown that breast tissue and the adult lung attenuates NIR light one order of magnitude every 2.5 cm, the attenuation rate in denser breast approaches one order of magnitude every 1.5 cm and the attenuation rate in brain and muscle is approximately one order of magnitude every 1.0 cm. In signal strength terms Fig. 13 plots fluorescence counts per second of exposure and square millimeter of of CCD detector area, as a function of organ diameter. This calculation is for a tumor-like lesion of 100 µl volume and 100 nM of Cy5.5 concentration (10 pico-moles) located near the center of the various organs simulated. The simulation is based on experimental measurements obtained from a diffuse volume (similar to the one shown on Fig. 11a but with varying outer diameter) using 30 mW of illuminating power [22] .
There are also three horizontal lines plotted, marking the 10-, 20-, and 30-dB signal-to-noise ratio (SNR) achieved assuming shot-noise limited detection. In reality, background fluorescence (primarily due to non-specific dye distribution) limits the SNR achieved, since background signals can be seen as "biologically induced noise" after appropriate subtraction schemes [63] . Data set optimization [62] and appropriate algorithms [64] can be used to image at low SNR and such considerations should be addressed on a case-to-case basis. This study, however, demonstrates that fluorescence imaging of human tissues becomes an issue of uptake-to-background contrast rather than of propagation feasibility. Important to the latter argument is that fluorescence offers mechanisms for multifold background suppression by using quenching and activation (dequenching) of fluorescent probes [25, 65] or fluorescence resonance energy transfer [66] . These technologies significantly minimize background signals in vivo and, combined with advances in drug delivery and hardware improvements, could surpass the predictions of this study.
Conclusion
Despite advances in medical imaging technologies over the past two decades, we are currently still limited in our ability to detect tumors or other diseases in their earliest stage of formation, phenotype tumors during complex cycles of growth, invasion and metastases, to use imaging techniques to speed up drug testing, and to use imaging as an objective endpoint for tailoring therapies in a given individual. Similar limitations also exist in neurodegenerative, cardiovascular, and immunologic diseases. Traditional cross-sectional imaging techniques, such as MR, CT, and ultrasound, primarily rely on physical (e.g.,
